To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Merlin to launch OGS buyout bid
Merlin Biosciences is in talks with Oxford GlycoSciences, which is currently the subject of a £101m offer from Celltech.
